Fig. 2From: Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in TanzaniaAll patients who give consent for participation and those that fulfil the inclusion criteriaBack to article page